TRIM32: Tripartite Motif Containing 32

E3 ubiquitin-protein ligase involved in muscle development, neuronal function, and tumor suppression

Gene Information Card

Symbol TRIM32
Full Name Tripartite Motif Containing 32
Gene Type Protein coding
Chromosomal Location 9q33.1
NCBI Gene ID 22954 ncbi.nlm.nih.gov/gene/22954
Ensembl ID ENSG00000104833
UniProt ID Q13049
OMIM ID 602290
HGNC ID 16380
Aliases BBS11, HT2A, LGMD2H, TATIP

Description

TRIM32 encodes a member of the tripartite motif (TRIM) family, characterized by RING finger, B-box, and coiled-coil domains. The protein functions as an E3 ubiquitin-protein ligase, targeting substrates for proteasomal degradation. It plays critical roles in skeletal muscle maintenance, neuronal development, and cell cycle regulation. Mutations in TRIM32 cause limb-girdle muscular dystrophy type 2H (LGMD2H) and Bardet-Biedl syndrome type 11 (BBS11).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Limb-girdle muscular dystrophy type 2H (LGMD2H) Loss-of-function mutations impair ubiquitin ligase activity, leading to defective protein turnover and muscle fiber degeneration. OMIM #254110; ClinVar
Bardet-Biedl syndrome 11 (BBS11) Biallelic mutations disrupt ciliary function via impaired ubiquitination of ciliary proteins. OMIM #615988; ClinVar
Sarcotubular myopathy Specific TRIM32 mutations cause abnormal sarcoplasmic reticulum and T-tubule morphology. OMIM #268920; NCBI Gene
Colorectal cancer TRIM32 overexpression promotes tumor growth via ubiquitination and degradation of p53. COSMIC; PubMed studies

Expression Profile

Tissue Expression
Tissue nTPM level
Skeletal muscle 48.2 High
Heart 32.1 Medium
Brain 18.5 Medium
Liver 8.3 Low
Kidney 6.7 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 22.4 Cervical cancer cell line
HepG2 15.8 Hepatocellular carcinoma
A549 12.1 Lung adenocarcinoma
SH-SY5Y 19.3 Neuroblastoma
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1459G>A (p.Asp487Asn) Missense Found in LGMD2H families Loss of E3 ligase activity
c.1460A>G (p.Asp487Gly) Missense Found in BBS11 patients Impaired substrate ubiquitination
c.1180C>T (p.Arg394Trp) Missense Rare Reduced protein stability
c.1573C>T (p.Arg525*) Nonsense Reported in LGMD2H Premature truncation, loss of function
Mutation functional classification

Loss of Function (LOF)

Most LGMD2H and BBS11 mutations result in loss of E3 ubiquitin ligase activity, leading to accumulation of substrates and cellular dysfunction.

Gain of Function (GOF)

Not well established; some cancer-associated overexpression may confer oncogenic gain-of-function via enhanced p53 degradation.

Dominant Negative (DN)

Not reported for TRIM32; all known pathogenic mutations are recessive.

Pathways

Ubiquitin mediated proteolysis (KEGG: hsa04120)
p53 signaling pathway (KEGG: hsa04115)
Ciliary assembly and transport

Protein Summary

TRIM32 is a 653-amino acid protein with an N-terminal RING finger domain (E3 ubiquitin ligase activity), two B-box domains, a coiled-coil region, and a C-terminal NHL repeat domain. It ubiquitinates diverse substrates including p53, actin, and ciliary proteins, thereby regulating cell proliferation, muscle integrity, and ciliary function. Subcellular localization is predominantly cytoplasmic and nuclear.

Related Products

Product name Cat.No. Species Gene ID
TRIM32 Knockout HEK293 Cell Line EDJ-KQ7754 Human 22954 Details Get a Quote
TRIM32 Knockout A-549 Cell Line EDJ-KQ33197 Human 22954 Details Get a Quote
TRIM32 Knockout HCT 116 Cell Line EDJ-KQ33198 Human 22954 Details Get a Quote
TRIM32 Knockout HeLa Cell Line EDJ-KQ33199 Human 22954 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: